Estazolam
Estazolam TZF contains the active substance estazolam, which belongs to a group of medicines called benzodiazepines. Estazolam has a sedative effect and a weaker anticonvulsant and muscle relaxant effect. Estazolam TZF is used for the short-term treatment of sleep disorders:
If the patient has:
General information about the effects observed after treatment with benzodiazepines and other medicines with similar effects to benzodiazepines, which should be taken into account when taking Estazolam TZF.
➢ Tolerance: After taking Estazolam TZF for several weeks, its effectiveness may decrease.
➢ Dependence: Long-term use of estazolam can lead to psychological and physical dependence. The risk of developing dependence increases with the dose and duration of treatment and is higher in patients addicted to drugs, alcohol, or patients with personality disorders.
➢ Withdrawal symptoms: In case of sudden withdrawal of the medication, the patient may experience withdrawal symptoms, such as headaches, muscle pain, increased anxiety, tension, excitement, restlessness, disorientation, sleep disturbances, irritability. In severe cases, the following may occur: loss of sense of reality, personality disorders, hypersensitivity to sound, touch, light, noise, feeling of tingling and numbness of limbs, hallucinations, and delusions, epileptic seizures.
➢ Rebound phenomenon and anxiety: When discontinuing Estazolam TZF, a transient recurrence of intensified symptoms that were the reason for taking the medication (so-called rebound phenomenon) may occur. These symptoms are often accompanied by mood changes, anxiety, sleep disturbances, and insomnia. To minimize the risk of these symptoms, it is recommended to gradually reduce the dose of the medication.
➢ Anterograde amnesia (inability to remember events after taking the medication): Estazolam may cause anterograde amnesia (difficulty learning and remembering new information - new data is not permanently stored). This condition usually occurs within a few hours of taking the medication, especially in high doses. If the doctor has prescribed Estazolam TZF to be taken once a day, to reduce the risk of anterograde amnesia, it is recommended to take the medication half an hour before going to bed and ensure adequate conditions for continuous, uninterrupted sleep lasting 7-8 hours.
➢ Psychiatric and paradoxical reactions: In children and the elderly, the risk of abnormal psychiatric and paradoxical reactions (opposite to expected) increases, such as anxiety, excitement, irritability, aggression, anger, fury, delusions, nightmares, hallucinations, psychoses, behavioral disorders. If such symptoms occur, the doctor should be informed immediately.
Specific patient groups
➢ Elderly patients should receive lower doses of Estazolam TZF (see section 3), due to the possibility of increased side effects, mainly orientation and motor coordination disorders (falls, injuries).
➢ Patients with liver or kidney failure or chronic respiratory failure should inform their doctor about these conditions before taking Estazolam TZF.
➢ Use in depression: Before taking Estazolam TZF, the doctor should be informed about any mental illnesses. Patients with symptoms of depression or anxiety related to depression should take several medications at the same time. Administering Estazolam TZF to patients with depression may exacerbate symptoms of depression, including suicidal thoughts.
➢ During the use of benzodiazepines, masked depression may be revealed.
➢ Patients with alcohol, drug, or medication addiction should inform their doctor about these addictions before taking Estazolam TZF. These patients are at high risk of developing psychological and physical dependence. Therefore, this group of patients should take Estazolam TZF only under strict medical supervision.
➢ Estazolam TZF in patients with porphyria may exacerbate symptoms of the disease. Patients with porphyria should inform their doctor about this disease before starting treatment with Estazolam TZF.
➢ During prolonged treatment with estazolam, the doctor usually orders periodic blood tests (morphology with smear) and urine analysis.
Tell your doctor about all medications you are currently taking or have recently taken, as well as any medications you plan to take. This is especially important if you are taking any of the following medications:
Alcohol: Drinking alcohol while taking Estazolam TZF may enhance its effect and lead to paradoxical reactions, such as psychomotor excitement, aggressive behavior (see section 2; Warnings and Precautions).
Before taking any medication, consult your doctor or pharmacist.
If you are pregnant or think you may be pregnant
If you suspect you are pregnant or plan to become pregnant, inform your doctor. Estazolam TZF should not be taken during pregnancy.
If you are breastfeeding
Estazolam TZF passes into breast milk. If treatment is necessary, breastfeeding should be discontinued.
Do not drive or operate machines while being treated with Estazolam TZF. The ability to drive or operate machines may be impaired due to the possibility of drowsiness, concentration disorders, or other side effects that reduce concentration (see section 4. Possible Side Effects).
The medication contains lactose monohydrate. If you have previously been diagnosed with intolerance to some sugars, you should contact your doctor before taking the medication.
Estazolam TZF contains less than 1 mmol (23 mg) of sodium per tablet, which means the medication is considered "sodium-free".
Estazolam TZF should always be taken as directed by your doctor. In case of doubts, consult your doctor.
Usually, 1 mg to 2 mg (1/2 to 1 tablet) is administered half an hour before bedtime.
The safety and efficacy of estazolam in children under 18 years of age have not been established.
The duration of treatment is determined by the doctor.
Estazolam TZF tablets should be taken orally, with a small amount of water, 30 minutes before bedtime. The doctor will start treatment with the lowest effective dose and, if necessary, will gradually increase it.
Symptoms of overdose are disorders of consciousness, drowsiness, slurred speech. In severe cases of poisoning, the following may occur: motor incoordination, hypotension, muscle weakness, respiratory disorders, coma. In case of taking a higher dose of Estazolam TZF than recommended, contact a doctor or go to the emergency department of the nearest hospital immediately. Take the medication in its original packaging so that the medical staff can check exactly which medication was taken.
If you forget to take a dose, take the next dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take the next dose as directed. If you forget to take two or more doses, consult your doctor.
Do not take a double dose to make up for a missed dose.
Do not stop treatment unless it is in accordance with your doctor's recommendation. It is possible that the symptoms of the disease will recur. If the doctor decides to discontinue treatment, the dose of the medication should be gradually reduced over several days.
In case of doubts related to the use of the medication, consult your doctor.
Like all medications, Estazolam TZF can cause side effects, although not everybody gets them.
If you experience any of the following side effects, tell your doctor immediately:
Rare side effects (occurring in less than 1 in 1,000 people):
Side effects with unknown frequency (frequency cannot be determined based on available data):
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medication.
Keep out of the sight and reach of children. Store in a temperature below 25°C. Store in the original packaging to protect from light and moisture. Do not use the medication after the expiration date (EXP) stated on the packaging. The expiration date refers to the last day of the given month. Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
The active substance of the medication is estazolam. One tablet contains 2 mg of estazolam. The other ingredients are potato starch, sodium carboxymethyl starch (type A), gelatin, quinoline yellow (E 104), talc, magnesium stearate, lactose monohydrate.
Yellow, round, flat tablets on both sides.
Packaging:20 or 28 tablets.
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A., ul. A. Fleminga 2, 03-176 Warsaw, phone: 22 811-18-14. For more detailed information about this medication, contact the representative of the marketing authorization holder.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.